Baseline characteristics of study participants
| Men (n=312,647) | Women (n=445,572) | Total (n=758,219) | |
| Age (years) | 61.5 (12.6) | 62.9 (12.5) | 62.3 (12.6) |
| Age group (%) | |||
| <40 | 4.8 | 3.8 | 4.2 |
| 40–49 | 11.7 | 9.6 | 10.4 |
| 50–59 | 25.6 | 23.4 | 25.5 |
| 60–69 | 30.8 | 30.4 | 30.6 |
| 70–79 | 20.0 | 21.6 | 21.0 |
| >=80 | 7.1 | 9.3 | 8.4 |
| Health insurance (%) | |||
| Third party | 78.8 | 68.6 | 72.8 |
| State | 20.4 | 30.8 | 26.5 |
| Special/exceptional | 0.9 | 0.6 | 0.7 |
| Race (%) | |||
| Black | 7.0 | 7.3 | 7.2 |
| Other | 93.0 | 92.7 | 92.9 |
| n for body mass index | 312 621 | 445 514 | 758 135 |
| BMI (kg/m2) | 27.7 (4.6) | 28.6 (5.6) | 28.2 (5.2) |
| BMI category (%) | |||
| Normal weight | 27.3 | 26.5 | 26.8 |
| Overweight | 44.8 | 37.7 | 40.6 |
| Obesity | 27.9 | 35.8 | 32.6 |
| n for blood pressure | 312 066 | 445 043 | 757 109 |
| SBP (mm Hg) | 124.0 (13.7) | 124.3 (13.9) | 124.2 (13.8) |
| DBP (mm Hg) | 76.6 (8.6) | 76.5 (8.5) | 76.6 (8.5) |
| n for HbA1c | 284 260 | 394 391 | 678 651 |
| HbA1c (%) | 7.46 (2.0) | 7.42 (2.0) | 7.44 (2.0) |
| HbA1c (mmol/mol) | 58 | 57 | 57 |
| n for blood lipids | 293 103 | 419 567 | 712 670 |
| Non-HDLc (mg/dL) | 137.1 (45.1) | 144.8 (46.3) | 141.6 (46.0) |
| LDLc (mg/dL) | 103.3 (37.7) | 110.9 (39.6) | 107.8 (39.0) |
| CKD stage (%)* | |||
| 1 | 47.3 | 41.7 | 44.0 |
| 2 | 39.6 | 42.0 | 41.0 |
| 3a | 8.0 | 11.2 | 9.9 |
| 3b | 2.9 | 3.5 | 3.2 |
| 4 | 0.9 | 0.9 | 0.9 |
| 5 | 1.3 | 0.7 | 1.3 |
| Urinary albumin excretion (%) | |||
| ˂30 mg/g or ˂20 mg/L | 71.1 | 78.7 | 75.5 |
| 30–299 mg/g or 20–199 mg/L | 23.4 | 17.8 | 20.2 |
| >=300 mg/g or >=200 mg/L | 5.5 | 3.6 | 3.4 |
| Hypertension (%) | 71.3 | 78.1 | 75.3 |
Data are means (SD) unless indicated otherwise.
*As reported by the treating physician to the NRCKD.
CKD, stages were defined according to the KDIGO classification; DBP, diastolic blood pressure; KDIGO, Kidney Disease: Improving Global Outcomes; LDLc, low-density lipoproteins cholesterol; non-HDLc, non-high density lipoproteins cholesterol; NRCKD, Colombian National Registry of Chronic Kidney Disease; SBP, systolic blood pressure.